{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:37:38Z","timestamp":1790710658786,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Developing novel drugs that can abrogate the growth and metastasis of malignant tumors is a major challenge for cancer researchers. Here we describe a novel synthetic retinoid, namely WYC-209, which inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs), known to resist conventional drug treatment, with an IC<jats:sub>50<\/jats:sub> of 0.19\u2009\u03bcM in a dose-dependent manner. WYC-209 also inhibits proliferation of TRCs of human melanoma, lung cancer, ovarian cancer, and breast cancer in culture. Interestingly, the treated TRCs fail to resume growth even after the drug washout. Importantly, the molecule abrogates 87.5% of lung metastases of melanoma TRCs in immune-competent wild-type C57BL\/6 mice at 0.22\u2009mg\u2009kg<jats:sup>\u22121<\/jats:sup> without showing apparent toxicity. Pretreating the melanoma TRCs with retinoic acid receptor (RAR) antagonists or with RAR siRNAs blocks or reduces the inhibitory effect of the molecule, suggesting that the target of\u00a0the molecule is RAR. WYC-209 induces TRC apoptosis and pretreating the TRCs with caspase 3 inhibitor or depleting caspase 3 with siRNAs substantially rescues growth of TRCs from WYC-209 inhibition, suggesting that WYC-209 induces TRCs apoptosis primarily via the caspase 3 pathway. Our findings demonstrate the promise of the new retinoid WYC-209 in treating malignant melanoma tumors with high efficacy and little toxicity.<\/jats:p>","DOI":"10.1038\/s41467-018-03877-7","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T14:23:29Z","timestamp":1523456609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Inhibition of cancer stem cell like cells by a synthetic retinoid"],"prefix":"10.1038","volume":"9","author":[{"given":"Junwei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1722-023X","authenticated-orcid":false,"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanlin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"3877_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"3877_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714\u2013726 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"3877_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader, J. E. & Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell. Stem. Cell. 10, 717\u2013728 (2012).","journal-title":"Cell. Stem. Cell."},{"key":"3877_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275\u2013284 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"3877_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nmat3361","volume":"11","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat. Mater. 11, 734\u2013741 (2012).","journal-title":"Nat. Mater."},{"key":"3877_CR6","volume":"5","author":"Y Tan","year":"2014","unstructured":"Tan, Y. et al. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat. Commun. 5, 4619 (2014).","journal-title":"Nat. Commun."},{"key":"3877_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep19304","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Efficient extravasation of tumor-repopulating cells depends on cell deformability. Sci. Rep. 6, 19304 (2016).","journal-title":"Sci. Rep."},{"key":"3877_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ajcn\/83.2.191","volume":"83","author":"KL Penniston","year":"2006","unstructured":"Penniston, K. L. & Tanumihardjo, S. A. The acute and chronic toxic effects of vitamin A. Am. J. Clin. Nutr. 83, 191\u2013201 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"3877_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman, M. S. et al. All-trans-retinoic acid in acute promyelocytic leukemia. New Engl. J. Med. 337, 1021\u20131028 (1997).","journal-title":"New Engl. J. Med."},{"key":"3877_CR10","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1074\/jbc.M807503200","volume":"284","author":"MYS Shih","year":"2009","unstructured":"Shih, M. Y. S. et al. Retinol esterification by DGAT1 is essential for retinoid homeostasis in murine skin. J. Biol. Chem. 284, 4292\u20134299 (2009).","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"3877_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000211162","volume":"6","author":"H Nau","year":"1993","unstructured":"Nau, H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin. Pharmacol. 6(Suppl 1), 35\u201344 (1993).","journal-title":"Skin. Pharmacol."},{"key":"3877_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"XH Tang","year":"2011","unstructured":"Tang, X. H. & Gudas, L. J. Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. Mech. Dis. 6, 345\u2013364 (2011).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"3877_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/156802612799436687","volume":"12","author":"AL Maire","year":"2012","unstructured":"Maire, A. L. et al. Retinoid receptors and therapeutic applications of RAR\/RXR modulators. Curr. Top. Med. Chem. 12, 505\u2013527 (2012).","journal-title":"Curr. Top. Med. Chem."},{"key":"3877_CR14","unstructured":"Chandraratna, R. A. Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. US Patent #5,089,509 (1989)."},{"key":"3877_CR15","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1248\/cpb.48.1504","volume":"48","author":"K Ohta","year":"2000","unstructured":"Ohta, K. et al. Retinoidal pyrimidinecarboxylic acids, unexpected diaza substituent effects in retinobenzoic acids. Chem. Pharm. Bull. 48, 1504\u20131513 (2000).","journal-title":"Chem. Pharm. Bull."},{"key":"3877_CR16","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1021\/jm00016a018","volume":"38","author":"MF Boehm","year":"1995","unstructured":"Boehm, M. F. et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38, 3146\u20133155 (1995).","journal-title":"J. Med. Chem."},{"key":"3877_CR17","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1021\/jo00129a060","volume":"60","author":"JM Brunel","year":"1995","unstructured":"Brunel, J. M. et al. Highly enantioselective oxidation of sulfides mediated by a chiral titanium complex. J. Org. Chem. 60, 8086\u20138088 (1995).","journal-title":"J. Org. Chem."},{"key":"3877_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2003.11.002","volume":"50","author":"J Vasudevan","year":"2004","unstructured":"Vasudevan, J. & Chandraratna, R. Rational design of tazarotene. J. Am. Aacd. Dermatol. 50, 148 (2004).","journal-title":"J. Am. Aacd. Dermatol."},{"key":"3877_CR19","first-page":"830","volume":"6","author":"G Shistik","year":"2007","unstructured":"Shistik, G., Prakash, A. V., Fenske, N. A. & Glass, L. F. Treatment of locally metastatic melanoma: a novel approach. J. Drugs Dermat. 6, 830\u2013832 (2007).","journal-title":"J. Drugs Dermat."},{"key":"3877_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"3877_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/jnci\/92.10.826","volume":"92","author":"M Widschwendter","year":"2000","unstructured":"Widschwendter, M. et al. Methylation and silencing of the retinoic acid receptor-beta 2 gene in breast cancer. J. Natl. Cancer I 92, 826\u2013832 (2000).","journal-title":"J. Natl. Cancer I"},{"key":"3877_CR22","first-page":"1125","volume":"10","author":"P Goodyer","year":"1995","unstructured":"Goodyer, P., Dehbi, M., Torban, E., Bruening, W. & Pelletier, J. Repression of the retinoic acid receptor-alpha gene by the Wilms\u2019 tumor suppressor gene product, wt1. Oncogene 10, 1125\u20131129 (1995).","journal-title":"Oncogene"},{"key":"3877_CR23","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1038\/sj.onc.1206044","volume":"21","author":"E Devarajan","year":"2002","unstructured":"Devarajan, E. et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21, 8843\u20138851 (2002).","journal-title":"Oncogene"},{"key":"3877_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/380723a0","volume":"380","author":"M Enari","year":"1996","unstructured":"Enari, M., Talanian, R. V., Wong, W. W. & Nagata, S. Sequential activation of ICE like and CPP32 like proteases during FAS mediated apoptosis. Nature 380, 723\u2013726 (1996).","journal-title":"Nature"},{"key":"3877_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755\u2013768 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"3877_CR26","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","volume":"13","author":"L Vermeulen","year":"2012","unstructured":"Vermeulen, L., de Sousa e Melo, F., Richel, D. J. & Medema, J. P. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 13, e83\u2013e89 (2012).","journal-title":"Lancet Oncol."},{"key":"3877_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nm.3839","volume":"21","author":"S Wei","year":"2015","unstructured":"Wei, S. et al. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nat. Med. 21, 457\u2013466 (2015).","journal-title":"Nat. Med."},{"key":"3877_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJMc1409040","volume":"371","author":"J Lehmann-Che","year":"2014","unstructured":"Lehmann-Che, J., Bally, C. & de Th\u00e9, H. Therapy resistance in APL. N. Engl. J. Med. 371, 1171\u20131172 (2014).","journal-title":"N. Engl. J. Med."},{"key":"3877_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"H de Th\u00e9","year":"2018","unstructured":"de Th\u00e9, H. Differentiation therapy revisited. Nat. Rev. Cancer 18, 117\u2013127 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"3877_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature19830","volume":"538","author":"A Kotschy","year":"2016","unstructured":"Kotschy, A. et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature 538, 477\u2013482 (2016).","journal-title":"Nature"},{"key":"3877_CR31","unstructured":"Kumar, B. V. S. et al. Process for the preparation of 4, 4-dimethyl-6-ethynylthiochroman. US Patent #6,963,002 (2004)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03877-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:35:07Z","timestamp":1671543307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-03877-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-03877-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1406"}}